新冠疫情对加拿大安大略省宫颈筛查、阴道镜及治疗服务的影响:一项基于人群的研究
这项基于人群的回顾性观察研究比较了2020年3月至8月与2019年同期安大略省宫颈筛查细胞学、阴道镜和治疗量。结果显示月均筛查量下降63.8%,阴道镜下降39.7%,治疗下降31.1%;每月平均少检出292例高级别细胞学异常,截至2020年8月仍有1159人等待阴道镜随访。
要点
- 疫情前6个月宫颈筛查月均量下降63.8%,阴道镜下降39.7%,治疗下降31.1%。
- 每月平均少检出292例高级别细胞学异常,降幅51.0%。
- 截至2020年8月,1159人(29.2%)高级别细胞学异常者仍在等待阴道镜。
核心结论
- 新冠疫情对安大略省宫颈筛查及随访服务造成显著影响,需持续监测服务利用以指导系统恢复。
研究设计与样本
- 基于人群的回顾性观察研究,纳入2019年1月至2020年8月至少完成一次宫颈筛查细胞学、阴道镜或宫颈不典型增生治疗操作的21-69岁有宫颈人群。
主要发现
- 2020年3月至8月,宫颈筛查细胞学月均量较2019年同月下降63.8%(范围-92.3%至-41.0%)。
- 阴道镜月均量下降39.7%(范围-75.1%至-14.3%),治疗月均量下降31.1%(范围-43.5%至-23.6%)。
- 2020年3月至8月,每月通过筛查检出的高级别细胞学异常平均减少292例(-51.0%)。
- 截至2020年8月,1159人(29.2%)因高级别筛查细胞学异常等待阴道镜随访。
临床怎么用
- 应加强宫颈筛查、阴道镜及治疗服务的恢复与监测,优先处理积压的高级别细胞学异常随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the immediate impact of the COVID-19 pandemic on cervical screening, colposcopy and treatment volumes in Ontario, Canada. DESIGN: Population-based retrospective observational study. SETTING: Ontario, Canada. POPULATION: People with a cervix age of 21-69 years who completed at least one cervical screening cytology test, colposcopy or treatment procedure for cervical dysplasia between January 2019 and August 2020. METHODS: Administrative databases were used to compare cervical screening cytology, colposcopy and treatment procedure volumes before (historical comparator) and during the first 6 months of the COVID-19 pandemic (March-August 2020). MAIN OUTCOME MEASURES: Changes in cervical screening cytology, colposcopy and treatment volumes; individuals with high-grade cytology awaiting colposcopy. RESULTS: During the first 6 months of the COVID-19 pandemic, the monthly average number of cervical screening cytology tests, colposcopies and treatments decreased by 63.8% (range: -92.3 to -41.0%), 39.7% (range: -75.1 to -14.3%) and 31.1% (range: -43.5 to -23.6%), respectively, when compared with the corresponding months in 2019. Between March and August 2020, on average 292 (-51.0%) fewer high-grade cytological abnormalities were detected through screening each month. As of August 2020, 1159 (29.2%) individuals with high-grade screening cytology were awaiting follow-up colposcopy. CONCLUSIONS: The COVID-19 pandemic has had a substantial impact on key cervical screening and follow-up services in Ontario. As the pandemic continues, ongoing monitoring of service utilisation to inform system response and recovery is required. Future efforts to understand the impact of COVID-19-related disruptions on cervical cancer outcomes will be needed. TWEETABLE ABSTRACT: COVID-19 has had a substantial impact on cervical screening and follow-up services in Ontario, Canada.
引用
- Meggetto O, Jembere N, Gao J, et al. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study. BJOG. 2021. PMID: 33982870. doi:10.1111/1471-0528.16741
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。